FFAR3 and influenza: Specifically, butyrate accumulates alternatively activated macrophages and amplifies influenza-specific CD8+ T cell activity in lungs in a GPR41-dependent manner (20), thereby potentiating systemic antiviral immunity, alleviating host pathological damage, and enhancing rapid viral clearance.